Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 45, 2023 - Issue 6
161
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke

, , , , , , , & show all
Pages 538-543 | Received 15 Jul 2022, Accepted 29 Dec 2022, Published online: 04 Jan 2023

References

  • Chen Y, Wright N, Guo Y, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. Lancet Glob Health. 2020;8(4):e580–90. DOI:10.1016/S2214-109X(20)30069-3
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50(12):e344–418. DOI:10.1161/STR.0000000000000211
  • Yang M, Huo X, Miao Z, et al. Platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban in acute ischemic stroke. Drugs. 2019;79(5):515–529. DOI:10.1007/s40265-019-01078-0
  • Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 1998;338(21):1488–1497. doi: 10.1056/NEJM199805213382102.
  • Wu C, Sun C, Wang L, et al. Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis. Stroke. 2019;50(12):3481–3487. DOI:10.1161/STROKEAHA.119.026240
  • Zhao W, Che R, Shang S, et al. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy. Stroke. 2017;48(12):3289–3294. DOI:10.1161/STROKEAHA.117.019193
  • Riscado LVS, de Pinho JHS, Lobato AC. Efficacy and safety of tirofiban bridge as an alternative to suspension of dual antiplatelet therapy in patients undergoing surgery: a systematic review. J Vasc Bras. 2021;20:e20210113.
  • Wang H, Li X, Liu C, et al. Effects of oral antiplatelet agents and tirofiban on functional outcomes of patients with non-disabling minor acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(8):104829. DOI:10.1016/j.jstrokecerebrovasdis.2020.104829
  • Zhang H, Lin F, Zhao Y, et al. Assessing the efficacy and safety of tirofiban in combination with dual-antiplatelet therapy in progressive ischemic stroke patients. J Cardiovasc Pharmacol. 2021;78(3):448–452. DOI:10.1097/FJC.0000000000001077
  • Gong J, Shang J, Yu H, et al. Tirofiban for acute ischemic stroke: systematic review and meta-analysis. Eur J Clin Pharmacol. 2020;76(4):475–481. DOI:10.1007/s00228-019-02817-8
  • Tao C, Zhu Y, Zhang C, et al. Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke. BMC neurol. 2021;21(1):237. DOI:10.1186/s12883-021-02268-8
  • Bin P, Bo W. Chinese Guidelines for the diagnosis and treatment of acute ischemic stroke 2018. Chin J Neurol. 2018;51(9):666–682.
  • Liu B, Zhang H, Wang R, et al. Early administration of tirofiban after urokinase-mediated intravenous thrombolysis reduces early neurological deterioration in patients with branch atheromatous disease. J Int Med Res. 2020;48(5):300060520926298. DOI:10.1177/0300060520926298
  • Nakase T, Sasaki M, Suzuki A. The effect of acute medication with cilostazol, an anti-platelet drug, on the outcome of small vessel brain infarction. J Stroke Cerebrovasc Dis. 2014;23(6):1409–1415.
  • Knottnerus IL, Govers-Riemslag JW, Hamulyak K, et al. Endothelial activation in lacunar stroke subtypes. Stroke. 2010;41(8):1617–1622. DOI:10.1161/STROKEAHA.109.576223
  • Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol. 2016;1(3):83–92.
  • Liu J, Shi Q, Sun Y, et al. Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(4):1126–1132. DOI:10.1016/j.jstrokecerebrovasdis.2018.12.044
  • Zhang C, Qin YY, Chen Q, et al. Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies. Int J Cardiol. 2014;174(3):669–677. DOI:10.1016/j.ijcard.2014.04.225
  • Jones SB, Loehr L, Avery CL, et al. Midlife alcohol consumption and the risk of stroke in the atherosclerosis risk in communities study. Stroke. 2015;46(11):3124–3130. DOI:10.1161/STROKEAHA.115.010601
  • Duan Y, Wang A, Wang Y, et al. Cumulative alcohol consumption and stroke risk in men. J Neurol. 2019;266(9):2112–2119. DOI:10.1007/s00415-019-09361-6
  • Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis. J Clin Neurosci. 2019;60:24–30.
  • Deng Z, Wu X, Hu L, et al. Risk factors for 30-day readmission in patients with ischemic stroke: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(10):11083–11105. DOI:10.21037/apm-21-2884
  • Yi SW, Shin DH, Kim H, et al. Total cholesterol and stroke mortality in middle-aged and elderly adults: a prospective cohort study. Atherosclerosis. 2018;270:211–217.
  • de Carvalho LSF. Total cholesterol and the risk of stroke: a double-edged sword or a blunt knife? Atherosclerosis. 2018;270:191–192.
  • Qu L. Modern research progress of progressive cerebral infarction. Mod Distance Educ Chin Med. 2010;8(5):174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.